Transcatheter valve-in-valve implantation using Corevalve Revalving System for failed surgical aortic bioprostheses.
暂无分享,去创建一个
P. Presbitero | M. Napodano | C. Tamburino | A. Ramondo | A. Petronio | F. Ettori | G. Santoro | F. Bedogni | G. Ussia | L. Testa | F. De Marco | N. Brambilla | M. Laudisa | S. Pizzocri | S. Klugman
[1] M. Mack,et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, The Journal of thoracic and cardiovascular surgery.
[2] M. Mack. Coronary obstruction following transcatheter aortic valve‐in‐valve implantation for failed surgical bioprostheses , 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[3] F. Maisano,et al. Incidence and Predictors of Early and Late Mortality After Transcatheter Aortic Valve Implantation in 663 Patients With Severe Aortic Stenosis , 2011, Circulation.
[4] Pascal Vranckx,et al. Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. , 2011, Journal of the American College of Cardiology.
[5] H. Eggebrecht,et al. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. , 2011, European heart journal.
[6] M. Zwahlen,et al. Incidence and predictors of atrioventricular conduction impairment after transcatheter aortic valve implantation. , 2010, The American journal of cardiology.
[7] S. Pocock,et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. , 2010, The New England journal of medicine.
[8] P. Serruys,et al. Persistent conduction abnormalities and requirements for pacemaking six months after transcatheter aortic valve implantation. , 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[9] G. Latsios,et al. VALVULAR AND STRUCTURAL HEART DISEASES Original Studies ‘‘Device Landing Zone’’ Calcification, Assessed by MSCT, as a Predictive Factor for Pacemaker Implantation After TAVI , 2010 .
[10] J. Rodés‐Cabau,et al. Transcatheter valve-in-valve implantation for the treatment of stentless aortic valve dysfunction. , 2010, The Journal of thoracic and cardiovascular surgery.
[11] Ronen Gurvitch,et al. Transcatheter Valve-in-Valve Implantation for Failed Bioprosthetic Heart Valves , 2010, Circulation.
[12] D. Hildick-Smith,et al. Transcatheter aortic valve implantation for stenosed and regurgitant aortic valve bioprostheses CoreValve for failed bioprosthetic aortic valve replacements. , 2010, Journal of the American College of Cardiology.
[13] A. Cheung,et al. Transcatheter valve-in-valve aortic valve implantation: 16-month follow-up. , 2009, The Annals of thoracic surgery.
[14] N. Jaussaud,et al. Risk of reoperation for aortic bioprosthesis dysfunction. , 2009, The Journal of heart valve disease.
[15] C. Ruiz,et al. First percutaneous transcatheter aortic valve‐in‐valve implant with three year follow‐up , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[16] G. Schuler,et al. Human minimally invasive off-pump valve-in-a-valve implantation. , 2008, The Annals of thoracic surgery.
[17] P. Wenaweser,et al. Percutaneous aortic valve replacement for severe aortic regurgitation in degenerated bioprosthesis: The first valve in valve procedure using the corevalve revalving system , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[18] Helmut Baumgartner,et al. Guidelines on the management of valvular heart disease The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology , 2007 .